Biomaterial-Based Regenerative Strategies for Volumetric Muscle Loss: Challenges and Solutions
Advances in Wound Care · 2025
DOI: 10.1089/wound.2024.0079 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Wound Care, 2025. Verfasst von Charlene W Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Biocompatible Materials, Tissue Scaffolds, Muscle, Skeletal, Tissue Engineering. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Significance: Volumetric muscle loss (VML) is caused by the loss of significant amounts of skeletal muscle tissue. VML cannot be repaired by intrinsic regenerative processes, resulting in permanent loss of muscle function and disability. Current rehabilitative-focused treatment strategies lack efficacy and do not restore muscle function, indicating the need for the development of effective regenerative strategies. Recent Advances: Recent developments implicate biomaterial-based approaches for promoting muscle repair and functional restoration post-VML. Specifically, bioscaffolds transplanted in the injury site have been utilized to mimic endogenous cues of the ablated tissue to promote myogenic pathways, increase neo-myofiber synthesis, and ultimately restore contractile function to the injured unit. Critical Issues: Despite the development and preclinical testing of various biomaterial-based regenerative strategies, effective therapies for patients are not available. The unique challenges posed for biomaterial-based treatments of VML injuries, including its scalability and clinical applicability beyond small-animal models, impede progress. Furthermore, production of tissue-engineered constructs is technically demanding, with reproducibility issues at scale and complexities in achieving vascularization and innervation of large constructs. Future Directions: Biomaterial-based regenerative strategies designed to comprehensively address the pathophysiology of VML are needed. Considerations for clinical translation, including scalability and regulatory compliance, should also be considered when developing such strategies. In addition, an integrated approach that combines regenerative and rehabilitative strategies is essential for ensuring functional improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Biology, The College of New Jersey, Ewing, New Jersey, USA.
- Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Institute of Regenerative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Woojin M Han
Förderung
- NIAMS NIH HHS
Zitieren
APA
Cai, C. W., Grey, J. A., Hubmacher, D., & Han, W. M. (2025). Biomaterial-Based Regenerative Strategies for Volumetric Muscle Loss: Challenges and Solutions. Advances in Wound Care. https://doi.org/10.1089/wound.2024.0079
Vancouver
Cai CW, Grey JA, Hubmacher D, Han WM. Biomaterial-Based Regenerative Strategies for Volumetric Muscle Loss: Challenges and Solutions. Advances in Wound Care. 2025. doi:10.1089/wound.2024.0079
BibTeX
@article{Cai2025,
author = {Cai, Charlene W and Grey, Josh A and Hubmacher, Dirk and Han, Woojin M},
title = {Biomaterial-Based Regenerative Strategies for Volumetric Muscle Loss: Challenges and Solutions},
journal = {Advances in Wound Care},
year = {2025},
doi = {10.1089/wound.2024.0079}
}
EUVIMED